Dr Thomas P Monath MD

See all

Dr. Monath is a Partner, Pandemic and Biodefense Fund, Kleiner Perkins Caufield & Byers. He is also Adjunct Professor, Harvard School of Public Health. Between 1992 and 2006, Dr Monath was Chief Scientific Officer and an Executive Director, Acambis (a publicly traded biopharmaceutical company) where he directed R&D on dengue, West Nile, Japanese encephalitis, yellow fever, Clostridium difficile , and smallpox vaccines for defense against bioterrorism.

Dr Thomas P Monath MD had content added. Chris Wong added that Brook Byers is Dr Thomas P Monath MD's 'colleague', John Denniston is his 'colleague', John Doerr is his 'colleague', and Juliet Flint is his 'colleague'. Chris Wong uploaded 2 images of Dr Thomas P Monath MD. Chris Wong tagged Dr Thomas P Monath MD as 'vc' and 'venture capitalist'. See More »

	LinkedIn The professional profile on LinkedIn for Dr Thomas P Monath MD. LinkedIn is a networking tool that helps users like Dr Thomas P Monath MD discover inside connections... www.linkedin.com/pub/2/69/231
	LinkedIn The professional profile on LinkedIn for Dr Thomas P Monath MD. LinkedIn is a networking tool that helps users like Dr Thomas P Monath MD discover inside connections... www.linkedin.com/pub/3/4a4/6b
	LinkedIn The professional profile on LinkedIn for Dr Thomas P Monath MD. LinkedIn is a networking tool that helps users like Dr Thomas P Monath MD discover inside connections... www.linkedin.com/pub/4/680/93a
	Starting world wars,... A brief history of BIG CHEMICAL... www.cannabisculture.com/news/gwbayer
	Dr. Horowitz - Aids, Ebola,... description www.healingcelebrations.com/smallpoxandanthrax.htm
	THE ANTHRAX_BAYER_NAZI... ... as well as possibly Dr. Thomas Monath, the Vice President of OraVax/Acambis and affiliated officials at Aventis. I've also urged an inquiry into ATCC curator Dr. Joshua Lederberg, and the... www.rumormillnews.com/cgi-bin/archive.cgi?read=15009
	Vaccination Liberation... anti-vaccination information and nationwide support groups www.vaclib.org/news/poxadverse.htm
	kpcb www.kpcb.com/team/index.php?thomas monath, m.d.
	Financial Statement "It's really a good time to be in the vaccine business," says Dr. Thomas P. Monath, research chief at Acambis Inc. www.vaccinetruth.org/finacial_statement.htm

Bill Joy colleague

Dana Mead colleague

Ajit Nazre colleague

Juliet Flint colleague

Matt Murphy colleague

John Denniston colleague